Pharmacy |
| ||
|
Xergic Telfast |
|
| ||
Home » Prescription Drugs 17 » Xergic Telfast Indications30 mg tablets: Relief of symptoms associated with seasonal allergic rhinitis in children aged 6 to 11 years.60 mg tablets: Relief of symptoms associated with allergic rhinitis in adults and children aged 12 years or older.120 mg tablets: Relief of symptoms associated with seasonal allergic rhinitis in adults and children aged 12 years or older.180 mg tablets: Relief of symptoms associated with seasonal allergic rhinitis or urticaria in adults and children aged 12 years or older.Dosage And AdministrationChildren aged 6 to 11 years:The recommended dosage of XERGIC 30 mg tablets is one tablet twice daily when required.Adults and children aged 12 years or older: 60 mg tablets: The recommended dosage of XERGIC is one 60 mg tablet twice daily when required.120 mg and 180 mg tablets: The recommended dosage of XERGIC 120 mg and 180 mg tablets is one tablet once daily when required. Dosage adjustment is not required in the elderly or in patients with hepatic or renal impairment. Buy Xergic Telfast and other Prescription Drugs 17 products online at Medstore. Buy Online at Medstore - Click Here!
About Xergic Telfast: Product Type: Prescription Drugs 17 Xergic ( Telfast Allegra Generic Fexofenadine ) Xergic (Telfast Allegra Generic Fexofenadine) Telfast Allegra Generic Fexofenadine 120mg Telfast Allegra Generic Fexofenadine Xergic
View more Prescription Drugs 17 Pharmacy: Dozens of patents for name-brand drugs are due to expire within the next 14 months, and generic drugs will replace some of the most popular and widely advertised drugs used today. For millions of people worldwide, this means switching from familiar brands like Lipitor to generic equivalents. How will this affect drug companies, and what will be the impact on people who depend on expensive prescription medication? Here, a brief guide: Which drugs are scheduled to go generic? Some real blockbusters. "In the next two years, six of the 10 top-selling drugs will lose their patents," says Chris Woolston in the Los Angeles Times. Lipitor, the world's best-selling drug, which is used to lower cholesterol, will be available as a generic in November of this year. Another best-seller, the blood thinner Plavix, will lose its patent in May 2012. Other well-known drugs with expiring patents include the arthritis treatment Enbrel, the anti-psychotic Zyprexa, as well as drugs for bipolar disorder, HIV, high cholesterol, and other conditions.
| ||
